PACS Group, Inc. PACS
Set alert
45.58 USD -2.23 -4.66%
At close
45.76 +0.18 +0.39%
Pre-market · Nov 3, 4:00 AM ET
45.45 Day range 47.80
10.31 52-week range 50.38
- YTD
- +18.73%
- 1 year
- +277.32%
- Open
- 47.77
- Prev close
- 47.81
- Mkt cap
- 7.21B
- Vol
- 874.80K
- Avg vol
- 797.89K
- EPS
- 1.71
- P/E
- 26.66
- Div yield
- 0.00%
More statistics
- Low
- 45.45
- High
- 47.80
- Forward P/E
- 16.66
- Beta
- -0.14
- Short ratio
- 5.27
- Inst. own
- 31.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 44.18
- 200-d avg
- 39.71
- 1y target
- 59.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 59.00 +29.4% upside
Now 45.58
- Target (low)
- 57.00
- Target (mean)
- 59.00
- Target (high)
- 62.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy2
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.58286 | 0.55 – 0.64429 | 0.4523 | +28.9% | 1.46B | +8.4% | 5 |
| Next quarter | 0.62515 | 0.57 – 0.70574 | 0.572 | +9.3% | 1.54B | +13.7% | 5 |
| Current year | 2.50 | 2.39 – 2.73 | 1.81 | +38.5% | 5.85B | +10.6% | 5 |
| Next year | 2.74 | 2.58 – 3.02 | 2.50 | +9.3% | 6.54B | +11.8% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 10, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 6, 2026 | UBS | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 8, 2026 | UBS | Maintained | Buy | Buy |
| May 18, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 13, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 4, 2026 | UBS | Maintained | Buy | Buy |
| Mar 4, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 20, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 6, 2025 | Macquarie | Maintained | Outperform | Outperform |
| Jan 6, 2025 | Truist Securities | Maintained | Buy | Buy |
| Dec 17, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Nov 18, 2024 | Stephens & Co. | Maintained | Overweight | Overweight |
| Oct 14, 2024 | Truist Securities | Maintained | Buy | Buy |
| Oct 9, 2024 | UBS | Initiated | — | Buy |
| Aug 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 13, 2024 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 13, 2024 | Citigroup | Maintained | Buy | Buy |
| Aug 13, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Jun 28, 2024 | Macquarie | Initiated | — | Outperform |
| May 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| May 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| May 15, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| May 14, 2024 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 6, 2024 | Stephens & Co. | Initiated | — | Overweight |
| May 6, 2024 | JP Morgan | Initiated | — | Overweight |
